Last reviewed · How we verify
Venitol Tab.
Venitol is a venotropic agent that improves venous tone and microcirculation by enhancing vascular endothelial function.
Venitol is a venotropic agent that improves venous tone and microcirculation by enhancing vascular endothelial function. Used for Chronic venous insufficiency, Varicose veins, Hemorrhoids.
At a glance
| Generic name | Venitol Tab. |
|---|---|
| Also known as | Purified and Micronized Flavonoid Fraction 500mg |
| Sponsor | Hanlim Pharm. Co., Ltd. |
| Drug class | Venotropic agent |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
Venitol works by strengthening venous wall integrity and promoting better blood flow in the microvascular system. It is believed to act through multiple mechanisms including improvement of endothelial function and reduction of capillary fragility, thereby enhancing overall circulatory efficiency in peripheral tissues.
Approved indications
- Chronic venous insufficiency
- Varicose veins
- Hemorrhoids
Common side effects
- Gastrointestinal disturbances
- Headache
- Dizziness
Key clinical trials
- Preoperative Micronized Flavonoid Fraction (MFF) Use in Multimodal Anesthesia in Anorectal Surgery (NA)
- Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Venitol Tab. CI brief — competitive landscape report
- Venitol Tab. updates RSS · CI watch RSS
- Hanlim Pharm. Co., Ltd. portfolio CI